EGFR and osteosarcoma: The inhibitory effects of ZD6474 on osteosarcoma cells in vitro are not related with the EGFR levels (Figure 1 and Figure 4A) furtherly suggests that ZD6474 is a multiple-target tyrosine kinase inhibitor and plays anti-pliferation role also via inhibiting other signal pathways.